Drug Reimbursement in Canada
By George Wyatt, MBA -
Published 01 September 2017
This article provides a high-level overview of the elements of prescription drug reimbursement in Canada and discusses the costs, processes and reimbursement plans associated with a number of federal health agencies and payers and describes some of the variety of drug plans in place.
Categories: Features, Canada, Health Canada, Biologics and biotechnology, Drugs, Reimbursement
Tags: Reimbursement, Coverage, Health Technology Assessment, HTA, Common Drug Review